Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKB518 in Patients With Lung Cancer
NCT07019675Phase 2Recruiting
- Sponsor
- Kelun-Biotech
- Start
- Aug 2025
- Primary completion
- Feb 2027
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of SKB518 in lung carcinoma, sponsored by Kelun-Biotech. Started Aug 2025; status: recruiting.
02
Drugs
SKB518
03
Conditions
lung carcinoma
Beyond the preview
Go deeper on NCT07019675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07019675.